One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients
Online-Only Appendix
Files in this Data Supplement:
This Article
-
Diabetes Care May 2009 vol. 32 no. 5 762-768
- AbstractFree
- Full Text
- Full Text (PDF)
- » Online-Only Appendix
Current Issue
From the Cover
- Driving mishaps among individuals with type 1 diabetes: a prospective study
- Projecting the future diabetes population size and related costs for the U.S.
- Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus
- Are metabolically normal but obese individuals at lower risk for all-cause mortality?
